HK1076735A1 - Antigen-specific ige antibody production inhibitors - Google Patents

Antigen-specific ige antibody production inhibitors

Info

Publication number
HK1076735A1
HK1076735A1 HK05108838A HK05108838A HK1076735A1 HK 1076735 A1 HK1076735 A1 HK 1076735A1 HK 05108838 A HK05108838 A HK 05108838A HK 05108838 A HK05108838 A HK 05108838A HK 1076735 A1 HK1076735 A1 HK 1076735A1
Authority
HK
Hong Kong
Prior art keywords
antibody production
ige antibody
antigen
specific ige
production inhibitors
Prior art date
Application number
HK05108838A
Inventor
Takeshi Takahashi
Shinya Nagabuchi
Yoshitaka Nakamura
Takaji Yajima
Tamotsu Kuwata
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Publication of HK1076735A1 publication Critical patent/HK1076735A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Mammalian (including human) IgE antibody production inhibitors and immunomodulatory compositions containing as the active ingredient lactoferrin (LF) or its hydrolyzate; and IFN- gamma production potentiators containing LF or its hydrolyzate and ceramides.
HK05108838A 2000-01-14 2005-10-06 Antigen-specific ige antibody production inhibitors HK1076735A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000005480 2000-01-14

Publications (1)

Publication Number Publication Date
HK1076735A1 true HK1076735A1 (en) 2006-01-27

Family

ID=18534145

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05108838A HK1076735A1 (en) 2000-01-14 2005-10-06 Antigen-specific ige antibody production inhibitors

Country Status (6)

Country Link
JP (1) JP4787445B2 (en)
CN (2) CN1205998C (en)
AU (1) AU782539B2 (en)
HK (1) HK1076735A1 (en)
NZ (1) NZ519957A (en)
WO (1) WO2001051079A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1581243A4 (en) * 2002-12-06 2008-01-02 Agennix Inc Oral lactoferrin in the treatment of sepsis
JP2005350452A (en) * 2004-05-14 2005-12-22 Meiji Milk Prod Co Ltd COMPOSITION HAVING IgE PRODUCTION-SUPPRESSING ACTIVITY AND METHOD FOR SUPPRESSING IgE PRODUCTION
JP5061143B2 (en) * 2009-03-12 2012-10-31 株式会社クロイスターズ Topical skin preparation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2626472B1 (en) * 1988-02-02 1991-06-14 Roussel Uclaf USE OF MILK PROTEINS FOR THE MANUFACTURE OF AN ANTI-VIRAL DRUG
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
JPH0559081A (en) * 1991-08-29 1993-03-09 Kirin Brewery Co Ltd New sphingoglycolipid, its production and use
FR2728793A1 (en) * 1994-12-28 1996-07-05 Oreal Compsns. for treating sensitive skin
DE19602108A1 (en) * 1996-01-22 1997-07-24 Beiersdorf Ag Substances effective against bacteria, parasites, protozoa, mycota and viruses
JP3888707B2 (en) * 1996-01-22 2007-03-07 森永乳業株式会社 Antiangiogenic agent
TW480282B (en) * 1996-04-24 2002-03-21 Ren Wen Corp Recombinant eucaryotic vector containing allergen gene and use of preventing and treating allergic disease thereof
JP3859270B2 (en) * 1996-07-26 2006-12-20 森永乳業株式会社 Apoptosis inducer
NZ500712A (en) * 1997-04-10 2002-10-25 Agennix Inc Use of a lactoferin product to inhibit the inflammatory activity of interleukin-1 beta in the treatment of allergen-induced inflammatory disorders
WO1999041266A1 (en) * 1998-02-12 1999-08-19 Emory University Sphingolipid derivatives and their methods of use

Also Published As

Publication number Publication date
AU782539B2 (en) 2005-08-04
CN1395490A (en) 2003-02-05
AU2551501A (en) 2001-07-24
NZ519957A (en) 2003-08-29
CN1626240A (en) 2005-06-15
WO2001051079A1 (en) 2001-07-19
CN100384472C (en) 2008-04-30
CN1205998C (en) 2005-06-15
JP4787445B2 (en) 2011-10-05

Similar Documents

Publication Publication Date Title
WO2001034801A3 (en) Recombinant gelatin in vaccines
WO2000061772A3 (en) Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
EP1536828A4 (en) Methods of delivery of exogenous proteins to the cytosol and uses thereof
AU2002322211A1 (en) Methods and compisitions for activation human t cells in vitro
AU2008243079A1 (en) Compositions and methods for generating an immune response
WO2002018572A3 (en) Membrane penetrating peptides and uses thereof
AU2001249380A1 (en) Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
NO20031159D0 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
WO2003010288A3 (en) Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
WO2003010291A3 (en) Treatment of immune disorders and b cell disorders
NO20044898L (en) New etonogestrel esters
AU1074902A (en) Kahalalide f
AU2002309486A1 (en) Methods and compositions for modulating the immune system of animals
PT1213974E (en) DIRECTLY COMPRESSIVE BRIGHT SUBSTANCE FOR TABLETS
AU2002256347A1 (en) Compositions and methods for the identification of protein interactions in vertebrate cells
HK1076735A1 (en) Antigen-specific ige antibody production inhibitors
BG100248A (en) Squalene synthetase inhibitors
MY127675A (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
WO2001034806A3 (en) Methods and compositions for screening using diphtheria toxin constructs
AU2002258525A1 (en) Telomerase expression repressor proteins and methods of using the same
WO2002102324A3 (en) Anti-arthropod vector vaccines methods of selecting and uses thereof
AU2003276844A1 (en) Formulations of modified antibodies and methods of making the same
AU2003239151A8 (en) Compositions and methods for the acceleration of protein secretion dynamics
AU2002345743A1 (en) Telomerase expression repressor proteins and methods of using the same

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130112